DD142336A5 - Verfahren zur herstellung neuer harnstoff-und amidoverbindungen - Google Patents

Verfahren zur herstellung neuer harnstoff-und amidoverbindungen Download PDF

Info

Publication number
DD142336A5
DD142336A5 DD79211405A DD21140579A DD142336A5 DD 142336 A5 DD142336 A5 DD 142336A5 DD 79211405 A DD79211405 A DD 79211405A DD 21140579 A DD21140579 A DD 21140579A DD 142336 A5 DD142336 A5 DD 142336A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
salts
item
acid
compounds
Prior art date
Application number
DD79211405A
Other languages
German (de)
English (en)
Inventor
Adrian Marxer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD142336A5 publication Critical patent/DD142336A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD79211405A 1978-03-08 1979-03-06 Verfahren zur herstellung neuer harnstoff-und amidoverbindungen DD142336A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH251978 1978-03-08

Publications (1)

Publication Number Publication Date
DD142336A5 true DD142336A5 (de) 1980-06-18

Family

ID=4235609

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79211405A DD142336A5 (de) 1978-03-08 1979-03-06 Verfahren zur herstellung neuer harnstoff-und amidoverbindungen

Country Status (28)

Country Link
US (2) US4292429A (fr)
EP (1) EP0004561B1 (fr)
JP (1) JPS54125668A (fr)
KR (2) KR820002098B1 (fr)
AR (2) AR225010A1 (fr)
AT (1) AT364375B (fr)
AU (1) AU531006B2 (fr)
CS (1) CS244656B2 (fr)
CY (1) CY1304A (fr)
DD (1) DD142336A5 (fr)
DE (1) DE2961198D1 (fr)
DK (1) DK95279A (fr)
ES (1) ES478342A1 (fr)
FI (1) FI70708C (fr)
GB (1) GB2016011B (fr)
GR (1) GR71998B (fr)
HK (1) HK80185A (fr)
HU (1) HU182940B (fr)
IL (1) IL56797A (fr)
MY (1) MY8700199A (fr)
NO (1) NO152606C (fr)
NZ (1) NZ189841A (fr)
OA (1) OA06201A (fr)
PH (1) PH16207A (fr)
PL (2) PL116762B1 (fr)
PT (1) PT69314A (fr)
SU (2) SU845779A3 (fr)
ZA (1) ZA791062B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338453A (en) 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use
DE3213509A1 (de) * 1982-04-10 1983-10-20 Basf Ag, 6700 Ludwigshafen N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung
JPS6133173A (ja) * 1984-07-25 1986-02-17 Torii Yakuhin Kk アミジン化合物
AU5234886A (en) * 1984-12-12 1986-07-01 MTD-Produkter I Smaland A.B. Method of preparing a hospital room or the like
GB8906198D0 (en) * 1989-03-17 1989-05-04 Ciba Geigy Ag Compounds
JP2008540362A (ja) * 2005-05-03 2008-11-20 ファルマ、マール、ソシエダード、アノニマ 抗腫瘍性テトラヒドロピリミジン
FR2901273B1 (fr) * 2006-05-19 2010-12-24 Anaconda Pharma Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
AU2009294225B2 (en) 2008-09-17 2013-07-18 William Kingston Tideway anchor system
WO2011108724A1 (fr) * 2010-03-04 2011-09-09 味の素株式会社 Agent prophylactique ou thérapeutique pour le diabète ou l'obésité
CA2791174C (fr) * 2010-03-04 2015-11-17 Ajinomoto Co., Inc. Derive d'alkylamine
CN102924380B (zh) * 2012-11-13 2014-12-31 齐鲁动物保健品有限公司 一种咪唑苯脲的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH234990A (de) * 1938-05-11 1944-10-31 Chem Ind Basel Verfahren zur Darstellung eines neuen therapeutisch wirksamen Amidins.
GB813525A (en) * 1956-07-09 1959-05-21 Socony Mobil Oil Co Inc Fuel oil composition
GB1082964A (en) * 1963-06-25 1967-09-13 Wellcome Found New substituted imidazolines and their preparation and use
US3455940A (en) * 1965-12-07 1969-07-15 Herbert C Stecker Certain halo and dihalo n-substituted salicylamides
GB1174349A (en) * 1966-08-25 1969-12-17 Boehringer Sohn Ingelheim Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
US3846071A (en) * 1969-02-12 1974-11-05 Petrolite Corp Process of inhibiting corrosion by treatment with phosphate-cyclic amidine salts
NL7415845A (nl) * 1973-12-26 1975-06-30 Upjohn Co Werkwijze voor het bevorderen van de productie van endogene prostaglandinen door zoogdieren, alsmede werkwijze ter bereiding van daarbij te gebruiken preparaten.
US4088766A (en) * 1975-06-25 1978-05-09 The Upjohn Company Urea containing compositions and methods
US4233451A (en) * 1976-05-20 1980-11-11 The Procter & Gamble Company Process for making imidazolinium salts
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use

Also Published As

Publication number Publication date
EP0004561B1 (fr) 1981-11-04
KR830000884B1 (ko) 1983-04-26
HK80185A (en) 1985-10-25
ES478342A1 (es) 1979-05-16
CY1304A (en) 1985-12-06
PH16207A (en) 1983-08-05
PL116762B1 (en) 1981-06-30
HU182940B (en) 1984-03-28
AU4490079A (en) 1979-09-13
US4420619A (en) 1983-12-13
OA06201A (fr) 1981-06-30
NO152606C (no) 1985-10-23
AR225010A1 (es) 1982-02-15
AU531006B2 (en) 1983-08-04
GR71998B (fr) 1983-08-26
NO790765L (no) 1979-09-11
SU923367A3 (ru) 1982-04-23
CS244656B2 (en) 1986-08-14
PL123150B1 (en) 1982-09-30
GB2016011A (en) 1979-09-19
PL213924A1 (fr) 1980-02-25
EP0004561A2 (fr) 1979-10-17
FI70708B (fi) 1986-06-26
JPS629109B2 (fr) 1987-02-26
AT364375B (de) 1981-10-12
DE2961198D1 (en) 1982-01-14
ZA791062B (en) 1980-03-26
KR820002098B1 (ko) 1982-11-05
PT69314A (de) 1979-04-01
GB2016011B (en) 1982-08-25
IL56797A (en) 1982-09-30
AR227286A1 (es) 1982-10-15
JPS54125668A (en) 1979-09-29
ATA171079A (de) 1981-03-15
FI790740A (fi) 1979-09-09
NZ189841A (en) 1982-03-09
EP0004561A3 (en) 1979-11-14
DK95279A (da) 1979-09-09
MY8700199A (en) 1987-12-31
US4292429A (en) 1981-09-29
NO152606B (no) 1985-07-15
FI70708C (fi) 1986-10-06
SU845779A3 (ru) 1981-07-07

Similar Documents

Publication Publication Date Title
EP0001279B1 (fr) Dérivés de l'imidazole leur procédé de préparation et leurs compositions pharmaceutiques
DE3008056C2 (fr)
EP0005828B1 (fr) Nouvelles dérivés de la phénylpipérazine substitués, médicaments les contenant et procédés pour leur préparation
EP0004561B1 (fr) Composés d'urée et d'amide, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation pour préparer des compositions pharmaceutiques
CH649995A5 (de) Piperazinderivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten.
DE2702537A1 (de) Neue piperazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2642331A1 (de) Basisch substituierte pyridincarboxamide
DE2824764A1 (de) Neue pyridylpiperazinderivate und verfahren zu ihrer herstellung
EP0589903B1 (fr) 5-mercaptothiazoles a substituant aminoalkyle, leur preparation et leur utilisation
WO1992022542A1 (fr) 2-amino-5-mercaptothiadiazoles a substituant aminoalkyle, leur fabrication et leur utilisation
EP0007525A1 (fr) Dérivés de la 2-(4-aminopipéridino)-3.4-dihydroquinoléine, procédés pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation
DE2425767A1 (de) 3-alkyl-9-aminoalkyl-1,2,3,4-tetrahydrocarbazole und ihre verwendung in arzneimitteln
CH651027A5 (de) Heterocyclische verbindungen, ihre herstellung und verwendung.
CH637107A5 (en) Process for preparing novel 1-aryloxy-2-hydroxy-3-aminopropanes
EP0154721A1 (fr) Dérivés d'alcanols, procédés pour leur préparation et médicaments contenant ces composés
AT365179B (de) Verfahren zur herstellung neuer harnstoff- und amido-verbindungen
DD210909A5 (de) Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen
DE3531504A1 (de) 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
DE2914051A1 (de) Antiarthritisches mittel und verfahren zur herstellung desselben
DE3726381A1 (de) Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD201594A5 (de) Verfahren zur herstellung von neuen polyazaheterocyclischen verbindungen
DE2228802A1 (de) Neue heterocyclische Verbindungen und Verfahren zu ihrer Herstellung
AT325620B (de) Verfahren zur herstellung von neuen triazolothienodiazepinverbindungen und deren säureadditionssalzen
WO1992022541A1 (fr) 2-amino-1,3,4-thiadiazoles a substituant aminoalkyle, leur preparation et leur utilisation
CH643833A5 (de) Aminoisochinolinderivate, verfahren zur herstellung derselben und solche verbindungen enthaltende arzneimittel.